Phase 3 study of aducanumab enrolling in Las Vegas, Ohio, Florida
Cleveland Clinic receives OK for first-in-human trial
Researchers review lessons from failed trials, reasons for residual hope
A quest to reduce inflammation, offer neuroprotection and enhance repair
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Research seeks MRI biomarkers of in vivo pathogenesis
An intact rib cage bolsters clinical relevance
A Glimpse into the Future of Spine Surgery
Permits anterior interbody fusions through small incisions
But will patients and oncologists accept it?
Clinical trial to launch in 2016
Advertisement
Advertisement